The face of high risk prostate cancer
Author:
Publisher
Springer Science and Business Media LLC
Subject
Urology
Link
http://link.springer.com/content/pdf/10.1007/s00345-008-0254-3.pdf
Reference13 articles.
1. D’Amico AV, Moul J, Carroll PR, Sun L, Lubeck D, Chen MH (2003) Cancer-specific mortality after surgery or radiation for patients with clinically localized prostate cancer managed during the prostate-specific antigen era. J Clin Oncol 21:2163–2172
2. Albertsen PC, Hanley JA, Gleason DF, Barry MJ (1998) Competing risk analysis of men aged 55–74 years at diagnosis managed conservatively for clinically localized prostate cancer. JAMA 280:975–980
3. Albertsen PC, Hanley JA, Fine J (2005) 20–year outcomes following conservative management of clinically localized prostate cancer. JAMA 293:2095–2101
4. Albertsen PC, Hanley JA, Penson DF, Barrows F, Fine J (2007) Thirteen-year outcomes following treatment for clinically localized prostate cancer in a population based cohort. J Urol 177:932–936
5. Epstein JI (2000) Gleason 2–4 adenocarcinoma of the prostate on needle biopsy. Am J Surg Pathol 24:477–478
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Robot-Assisted Radical Prostatectomy in Locally Advanced Prostate Cancer;Robotic Urology;2024
2. Neoadjuvant Cabazitaxel plus Abiraterone/Leuprolide Acetate in Patients with High-Risk Prostate Cancer: ACDC-RP Phase II Trial;Clinical Cancer Research;2023-07-13
3. Chapter 9 Bitter Melon Extract and Pro state Cancer Therapy;Traditional Herbal Medicines for Modern Times;2016-12
4. Intense Androgen-Deprivation Therapy With Abiraterone Acetate Plus Leuprolide Acetate in Patients With Localized High-Risk Prostate Cancer: Results of a Randomized Phase II Neoadjuvant Study;Journal of Clinical Oncology;2014-11-20
5. Abiraterone Acetate: Targeting Persistent Androgen Dependence in Castration-Resistant Prostate Cancer;Advances in Therapy;2013-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3